Celavie Biosciences

Celavet Animal Health

Sandy Solmon CEO & President Celavie

Sandy Solmon wears several hats, she leads a private, emerging medical technology company that develops stem cell-based regenerative therapies for the treatment of CNS disorders and she is CEO, chief innovator, and founder of Sweet Street Desserts, the world’s largest manufacturer of frozen gourmet desserts. From R&D to regulations, she discusses how running a global food company translates to an emerging biotech company.

Read the full article here

Contact Celavie Biosciences

Changing the Paradigm of Regenerative Medicine and Stem Cell Technology